You searched for "wellbeing"

1329 results found

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

From patient to performer

Peter Cawrey lives in Harpenden, Hertfordshire, with his wife Dorothy. He had a salvage laryngectomy for squamous cell carcinoma in 2015, three years following his initial radiotherapy. Due to complications and a complex recovery, he has elected not to have...

From the editor March/April 2024

Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk Changes are afoot here at ENT & Audiology News, so loyal readers will notice a few differences for March/April...

A legendary ‘parotid adenoma’: teaching aid or trophy? & The stapes: a classical heresy

A legendary ‘parotid adenoma’: teaching aid or trophy? A wander through the glass cases of the newly refurbished Hunterian Museum at the Royal College of Surgeons in London presents a particularly impressive sight to any ENT surgeon. The salivary adenoma...

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...

The Laryngeal Pacemaker – developing an innovative solution for bilateral vocal fold paralysis

Bilateral vocal fold paralysis is a difficult condition to manage, with surgical interventions previously limited to tracheostomy or arytenoidectomy. Re-innervation surgery has been developed and, in recent years, a Laryngeal Pacemaker is now in clinical trials. We speak to two...

Controlled clinical trial results for FDA-approved tinnitus treatment device Lenire published in Nature Communications

Nature Communications has published the peer-reviewed results of Neuromod Devices’ TENT-A3 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A3) clinical trial for the first and only FDA-approved bimodal tinnitus treatment device, Lenire.

How will our grandchildren view COVID-19?

Alan Johnson, known to our readers as the former President of ENT UK, gives us his thoughts on the COVID pandemic, looking at it through the lens of other health crises. As I write, COVID-19 is displacing almost all other...

Winners announced for 2024 Hearing Technology Innovator Awards

Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has today revealed the winners of its fifth annual Hearing Technology Innovator Awards™. Through this esteemed awards programme, HHTM continues to honour innovation...

Medical Journals and The Journal of Laryngology and Otology

Medical journals have a fascinating history. One early journal, The Lancet, was founded in 1823 and its first Editor, London surgeon Thomas Wakley (1795-1862), had a turbulent life. He lived in an era where quackery was rife and where the...

Cambodian Otology Fellowship report

Further to a Humanitarian News article published in the November/December 2014 issue of ENT and Audiology News (see article here), this is a report of Charlie Huins’ six-month experience as the first ENT Fellow at the Children’s Surgical Centre (CSC),...

In conversation with Shelly Chadha

This year’s theme for World Hearing Day 2018 on 3 March is discussed by Shelly Chadha of the World Hearing Organization (WHO). She explains the importance of the event and how every hearing care professional can get involved and contribute...